NCT03832985 2026-04-09
Pediatric Reporting of Adult-Onset Genomic Results
Geisinger Clinic
Phase EARLY_PHASE1 Completed
Clinical Trials
8 trialsNCT04721886 2026-04-02
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT04278989 2026-03-25
Inhibition of Oral Tumorigenesis by Antitumor B
Medical College of Wisconsin
Phase EARLY_PHASE1 Completed
NCT04188665 2026-03-20
Using MASL to Combat Oral Cancer
Rowan University
Phase EARLY_PHASE1 Completed
NCT03276832 2026-03-19
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
NCT02603887 2026-01-29
Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT04018053 2026-01-27
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
Brigham and Women's Hospital
Phase EARLY_PHASE1 Active not recruiting